Rebecca Miksad, Md, Mms, Mph

Rebecca Miksad, Md, Mms, Mph Email and Phone Number

Mission-driven Chief Medical Officer and Digital Health Strategist | I accelerate value in Oncology, Data Science & Virtual Health through patient-centric, physician-led technology and direct multidisciplinary care @ Color
Rebecca Miksad, Md, Mms, Mph's Location
Boston, Massachusetts, United States, United States
About Rebecca Miksad, Md, Mms, Mph

I am a mission-driven Physician-Scientist and Digital Health Strategist committed to enhancing patient lives through science, technology, and data. I specialize in accelerating impactful healthcare technology, AI, and digital solutions by focusing on strategic value creation and integration within complex healthcare ecosystem. I work with life sciences, tech and AI companies, the US FDA, non-profits, hospitals and healthcare systems and advise companies from TechStars, Moonshot CancerX and and London-based Entrepreneurs First. I serve on Advisory Boards such as the University of Virginia Accelerating Innovations Fund.To succeed in the rapidly evolving technology and AI for healthcare sector, leaders must 1) Disrupt while satisfying ethical, equity, and US and International regulatory guidelines 2) Prioritize investments that solve the right problems in healthcare with the right technology that can be validated, measured, implemented within existing workflows and scaleableI drive impactful innovation in healthcare and drug development by streamlining access to the ecosystem and bridge the often unseen gaps between data, science, technology, care providers and patients.My clinical and scientific validation and strategic alignment approaches centers on five key pillars of healthcare technology: 1) Developing fit-for-purpose healthcare technology and AI solutions. 2) Creating value for patients, clinicians, and healthcare systems. 3) Optimizing data-driven tools, predictors, and outputs. 4) Validating scientific, operational, and patient outcomes. 5) Addressing regulatory, equity, and ethical considerations.To empower companies, scientists, and entrepreneurs in addressing complex healthcare and research challenges, I leverage: - Extensive leadership experience across US and international startup, regulatory, clinical trial, pharmaceutical, and research settings. - Deep expertise in medicine, drug development, data and decision science, AI, and healthtech. - Proven achievements in delivering first-in-class healthtech products and services, validating gold- standard real-world data endpoints with the FDA, doubling clinical trial enrollment and revenue, and founding and leading impactful cross-functional teams and organizations.I invite you to connect and discuss how we can work together to transform healthcare for a healthier future.Explore my scientific contributions https://tinyurl.com/Miksad-PubMed

Rebecca Miksad, Md, Mms, Mph's Current Company Details
Color

Color

View
Mission-driven Chief Medical Officer and Digital Health Strategist | I accelerate value in Oncology, Data Science & Virtual Health through patient-centric, physician-led technology and direct multidisciplinary care
Rebecca Miksad, Md, Mms, Mph Work Experience Details
  • Color
    Chief Medical Officer
    Color Sep 2024 - Present
    Burlingame, California, Us
    Excited to drive health equity in cancer outcomes through data-driven, tech-enabled cancer care.Color is the nation’s first fully-integrated Virtual Cancer Clinic. We deliver high quality patient-centered and technology enhanced care across the cancer care continuum: from cancer screening, risk assessment and prevention to cancer diagnosis, treatment support and survivorship. We meet the patient where they are through holistic physician-led multidisciplinary virtual care, home cancer screening and expert navigation of the complex landscape of cancer care
  • Miksad Md Consulting, Llc
    Founder And Ceo
    Miksad Md Consulting, Llc Oct 2023 - Present
    We accelerate real world data and digital solutions from innovation into impact. Success, sustainability and scaling requires bridging the large, and often invisible, divides within the complex and highly regulated healthcare and drug-development ecosystem. We leverage decades of extensive experience in the clinical, research and tech ecosystems to guide your team 1) Developing fit-for-purpose solutions 2) Creating value for patients, clinicians, and healthcare systems 3) Validating scientific, operations, and patient outcomes 4) Addressing regulatory, equity, and ethical considerations 5) Accessing and partnering with strategic healthcare stakeholders and customersWe have worked with large companies and healthcare systems and emerging companies from TechStars, CancerX, Harvard Innovation Lab and London-based Entrepreneurs First. Dr. Miksad serves on Advisory Boards such as the University of Virginia Accelerating Innovations Fund.
  • Boston University School Of Medicine
    Associate Professor Of Medicine
    Boston University School Of Medicine Mar 2019 - Present
    Boston, Ma, Us
    ● Internationally recognized researcher and sought after speaker● 100+ scientific publications in clinical trials, real-world data and health equity clinical trials, real-world evidence, health equity in journals such as JAMA Open Network, JCO and JCO Clinical Informatics, JNCI, Nature Digital Medicine, society guidances and books ● 100+ invited national and international presentations on clinical research, real-world evidence and health equity in scientific, industry, regulatory forums. Media coverage.● Scientific Publications available on PubMed (https://shorturl.at/dmOS0); H-index = 39, as of Oct 2023)
  • Boston University School Of Medicine
    Head, High Risk Cancer Genetics Clinic
    Boston University School Of Medicine Apr 2023 - Present
    Boston, Ma, Us
    ● Established first HRGC clinic for historically underserved patients in Boston
  • Boston University School Of Medicine
    Attending Physician, Oncology
    Boston University School Of Medicine Mar 2019 - Present
    Boston, Ma, Us
    ● Cancer Genetics expert. Deliver personalized, guideline-based screening recommendations● Oncology expert: Deliver state-of-the art, multidisciplinary diagnosis, treatment, clinical trials, research, surveillance and screening with a strong multi-disciplinary team: colon, rectal, pancreatic, anal, appendix and hepatocellular/liver cancer
  • American Society For Clinical Pharmacology & Therapeutics
    Associate Editor - Rwe, Rwd And Oncology For Clinical Pharmacology & Therapeutics (Cpt) Journal
    American Society For Clinical Pharmacology & Therapeutics Jan 2024 - Present
    Alexandria, Va, Us
    My goal is to identify and publish the most impactful and scientifically rigorous research that moves the field of medicine forward.CPT is the flagship journal of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), and is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted advances in the nature, action, efficacy, and evaluation of therapeutics.
  • Flatiron Health
    Head Of Research Unit, Senior Medical Director Ii Group Lead
    Flatiron Health Mar 2022 - Oct 2023
    New York, New York, Us
    Summary: I joined Flatiron Health pre-acquisition and the scope of my roles grew with the company and multiple promotions: From clinical and research development lead of early products and services to Founder and Head of Flatiron's Research Unit, Head of Strategic Affairs (a Medical Affairs function) and senior strategy leader reporting to the Chief Medical Officer.● Spearheaded and launched Flatiron’s inaugural Research Unit; Collaborated with executive leadership to secure resources; Authored first Scientific Strategic Plan to position Flatiron at forefront of innovation● Accountable for three Research Areas: 1) Health Equity, 2) FDA Research Collaboration / Post Marketing Commitments, 3) HTA / Drug Access ● Delivered internal and external products and services: Thought Leadership (20+ publications/invited presentations in first year) and Product Enablement (new methods and product feature). ● Fostered a strong culture of integrity and patient-centric research ● Accountable for Flatiron’s sole, organization-wide research protocol as PI.
  • Flatiron Health
    Head Of Strategic Affairs, Senior Medical Director Ii Group Lead
    Flatiron Health Aug 2021 - Oct 2023
    New York, New York, Us
    ● Prospectively identified evolving business needs and strategically redefined mission of function (Publications, Medical Writing and IRB Operations; Increased internal and external customer satisfaction by cultivating a customer-first ethos ● Created first research standards; established first Standard Operating Procedures with other functions and business units● Responsible for creating complex budget and implemented cost containment measures● Managed employed professionals, contractors and vendors.● Selected for competitive Leadership Development Program (2021) and Inclusive Leadership program (2022)
  • Flatiron Health
    Health Equity Champion
    Flatiron Health Aug 2021 - Oct 2023
    New York, New York, Us
    ● Created and defined first Director of Health Equity role; Established first Health Equity strategy ● Championed success of Health Equity as a business opportunity, which was adopted as 1 of 4 company-wide strategic pillars.
  • Flatiron Health
    Head Of Academic Research, Senior Medical Director Team Lead
    Flatiron Health Feb 2020 - Aug 2021
    New York, New York, Us
    ● Lead Academic Research team; set strategy and oversee research collaborations with investigators at Academic Institutions. ● Owned relationships with Cancer Centers● Led clinical machine-learning patent team
  • Flatiron Health
    Senior Medical Director I, Research Oncology Team Lead
    Flatiron Health Jul 2017 - Aug 2020
    New York, New York, Us
    ● Led clinical team to develop some of Flatiron Health's first products and services in the market● Established market value of real world evidence (RWE) and generated market demand through advancement of analytic methods and conducting research showcasing client and regulatory-relevant use cases ● Published critical recommendations for the field cited in FDA guidances
  • Harvard Medical School
    Assistant Professor
    Harvard Medical School 2010 - Jul 2018
    Boston, Ma, Us
    ● 100+ scientific publications in clinical trials, real-world data and health equity clinical trials, real-world evidence, health equity in journals such as JAMA Open Network, JCO and JCO Clinical Informatics, JNCI, Nature Digital Medicine, society guidances and books ● Conducted a large portfolio of funded clinical trial health services research, garnering international recognition● Awarded multiple research grants: NIH K23 five year grant, industry and foundation. Funded full research salary● Pioneered and published first Bayesian sequential trial analysis.● Chair, Scientific Committees and member of multiple national Society and NIH committeess● Selected for competitive Faculty Leadership Program● Scientific Publications available on PubMed (https://shorturl.at/dmOS0); H-index = 39, as of Oct 2023)
  • Harvard Medical School
    Instructor
    Harvard Medical School Jul 2007 - Jul 2010
    Boston, Ma, Us
  • Massachusetts General Hospital
    Senior Scientist, Institute For Technology Assessment
    Massachusetts General Hospital 2008 - Jul 2017
    Boston, Ma, Us
    ● Conducted large portfolio of funded decision-science research● Contributed research and clinical expertise as part of collaborative research team
  • Massachusetts General Hospital
    Research Fellow, Program In Cancer Outcomes Research Training (Pcort)
    Massachusetts General Hospital Jul 2006 - Jul 2008
    Boston, Ma, Us
  • Beth Israel Deaconess Medical Center
    Director, Gastrointestinal Oncology
    Beth Israel Deaconess Medical Center Jul 2007 - Jul 2017
    Boston, Ma, Us
    ● Reported to Chief of Hematology & Oncology; Represented faculty on multiple Division and hospital-wide clinical and administrative committees● Revamped GI Cancer Clinical Trial Program, ensuring successful external audit; Accelerated trial enrollment and revenue, achieving 100% increase in 2 years; Managed large (10+ MDs, 7 staff, 50+ trials).cross-disciplinary clinical trial program with a broad portfolio of Phase I to IV trials (Industry, cooperative group, investigator initiated). ● Contributed expertise to multiple National and international industry Clinical Trial Steering Committee and Safety Committee; Served on the Dana Farber / Harvard Cancer Center Human Subjects Protections Committee.● Conducted numerous clinical trials Phase I, II, III and IV trials as Principal Investigator (PI) at at Dana Farber/ Harvard Cancer Center ● Wrote, secured industry funding and served as PI, Sponsor and Medical Monitor for published multi-site Phase II, Investigator Initiated double-blind RCT. ● Founded two multidisciplinary clinics, boosting patient services and generating downstream revenue. ● Chair, Scientific Committees and member of multiple national Society and NIH committeess
  • Beth Israel Deaconess Medical Center
    Fellow, Hematology And Oncology
    Beth Israel Deaconess Medical Center Jul 2004 - Jun 2007
    Boston, Ma, Us
  • Newyork-Presbyterian Hospital
    Chief Medical Resident, Internal Medicine
    Newyork-Presbyterian Hospital Jul 2003 - Jun 2004
    New York, New York, Us
    ● Drove clinical, education and administrative aspects of Internal Medicine Residency program with 130 residents● Supervised clinical performance, set agendas for daily clinical and education conferences, presented 50+ didactic lectures● Managed scheduling and staffing ● Promoted resident physician well-being● Represented Department on hospital-wide committees
  • Newyork-Presbyterian Hospital
    Intern And Resident, Internal Medicine
    Newyork-Presbyterian Hospital Jul 2001 - Jun 2004
    New York, New York, Us
    ● Delivered high quality in-patient and outpatient care for patients with a broad range of medical diagnoses● Authored and published book (2008) still in print in Oct 2023: "Internal Medicine: A Concise Review for the Specialty Boards" as part of Last Minute study guide series.
  • Memorial Sloan-Kettering Cancer Center
    Intern And Resident, Internal Medicine
    Memorial Sloan-Kettering Cancer Center Jul 2001 - Jun 2004
    New York, Ny, Us
    ● Oversaw Crisis Management discharge of patients with cancer on September 11, 2021 to accommodate 9/11 survivors● Senior resident accountable for large in-patient oncology services

Rebecca Miksad, Md, Mms, Mph Education Details

  • Harvard Medical School
    Harvard Medical School
    Medical Science (Clinical Investigation Training Program)
  • Harvard T.H. Chan School Of Public Health
    Harvard T.H. Chan School Of Public Health
    Clinical Effectiveness And Decision Analysis
  • Joan & Sanford I. Weill Medical College Of Cornell University
    Joan & Sanford I. Weill Medical College Of Cornell University
    Honors In Research
  • Harvard University
    Harvard University
    Economics

Frequently Asked Questions about Rebecca Miksad, Md, Mms, Mph

What company does Rebecca Miksad, Md, Mms, Mph work for?

Rebecca Miksad, Md, Mms, Mph works for Color

What is Rebecca Miksad, Md, Mms, Mph's role at the current company?

Rebecca Miksad, Md, Mms, Mph's current role is Mission-driven Chief Medical Officer and Digital Health Strategist | I accelerate value in Oncology, Data Science & Virtual Health through patient-centric, physician-led technology and direct multidisciplinary care.

What schools did Rebecca Miksad, Md, Mms, Mph attend?

Rebecca Miksad, Md, Mms, Mph attended Harvard Medical School, Harvard T.h. Chan School Of Public Health, Joan & Sanford I. Weill Medical College Of Cornell University, Harvard University.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.